Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study.
Saved in:
| Title: | Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study. |
|---|---|
| Authors: | Di Gregorio, Maria (AUTHOR), Torri Clerici, Valentina Liliana Adriana (AUTHOR), Fenu, Giuseppe (AUTHOR), Gaetani, Lorenzo (AUTHOR), Gallo, Antonio (AUTHOR), Cavalla, Paola (AUTHOR), Ragonese, Paolo (AUTHOR), Annovazzi, Pietro (AUTHOR), Gajofatto, Alberto (AUTHOR), Prosperini, Luca (AUTHOR), Landi, Doriana (AUTHOR), Nicoletti, Carolina Gabri (AUTHOR), Di Carmine, Caterina (AUTHOR), Totaro, Rocco (AUTHOR), Nociti, Viviana (AUTHOR), De Fino, Chiara (AUTHOR), Ferraro, Diana (AUTHOR), Tomassini, Valentina (AUTHOR), Tortorella, Carla (AUTHOR), Righini, Isabella (AUTHOR) |
| Source: | European Journal of Neurology. Apr2021, Vol. 28 Issue 4, p1299-1307. 9p. |
| Subjects: | Magnetic resonance imaging, Multiple sclerosis, Prognosis, Immunoglobulin G, Young adults |
| Abstract: | Background and purpose: Tumefactive multiple sclerosis (TuMS) (i.e., MS onset presenting with tumefactive demyelinating lesions [TDLs]) is a diagnostic and therapeutic challenge. We performed a multicentre retrospective study to describe the clinical characteristics and the prognostic factors of TuMS. Methods: One hundred two TuMS patients were included in this retrospective study. Demographic, clinical, magnetic resonance imaging (MRI), laboratory data and treatment choices were collected. Results: TuMS was found to affect women more than men (female:male: 2.4), with a young adulthood onset (median age: 29.5 years, range: 11–68 years, interquartile range [IQR]: 38 years). At onset, 52% of TuMS patients presented with the involvement of more than one functional system and 24.5% of them with multiple TDLs. TDLs most frequently presented with an infiltrative MRI pattern (38.7%). Cerebrospinal fluid immunoglobulin G oligoclonal bands were often demonstrated (76.6%). In 25.3% of the cases, more than one acute‐phase treatment was administered, and almost one‐half of the patients (46.6%) were treated with high‐efficacy treatments. After a median follow‐up of 2.3 years (range: 0.1–10.7 years, IQR: 3.4 years), the median Expanded Disability Status Scale (EDSS) score was 1.5 (range: 0–7, IQR: 2). Independent risk factors for reaching an EDSS score ≥3 were a higher age at onset (odds ratio [OR]: 1.08, 95% confidence interval [CI]: 1.03–1.14, p < 0.01), a higher number of TDLs (OR: 1.67, 95% CI: 1.02–2.74, p < 0.05) and the presence of infiltrative TDLs (OR: 3.34, 95% CI: 1.18–9.5, p < 0.001) at baseline. Conclusions: The management of TuMS might be challenging because of its peculiar characteristics. Large prospective studies could help to define the clinical characteristics and the best treatment algorithms for people with TuMS. [ABSTRACT FROM AUTHOR] |
| Copyright of European Journal of Neurology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 149130978 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Di+Gregorio%2C+Maria%22">Di Gregorio, Maria</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Torri+Clerici%2C+Valentina+Liliana+Adriana%22">Torri Clerici, Valentina Liliana Adriana</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fenu%2C+Giuseppe%22">Fenu, Giuseppe</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gaetani%2C+Lorenzo%22">Gaetani, Lorenzo</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gallo%2C+Antonio%22">Gallo, Antonio</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cavalla%2C+Paola%22">Cavalla, Paola</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ragonese%2C+Paolo%22">Ragonese, Paolo</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Annovazzi%2C+Pietro%22">Annovazzi, Pietro</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gajofatto%2C+Alberto%22">Gajofatto, Alberto</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Prosperini%2C+Luca%22">Prosperini, Luca</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Landi%2C+Doriana%22">Landi, Doriana</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nicoletti%2C+Carolina+Gabri%22">Nicoletti, Carolina Gabri</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Di+Carmine%2C+Caterina%22">Di Carmine, Caterina</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Totaro%2C+Rocco%22">Totaro, Rocco</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nociti%2C+Viviana%22">Nociti, Viviana</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22De+Fino%2C+Chiara%22">De Fino, Chiara</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ferraro%2C+Diana%22">Ferraro, Diana</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tomassini%2C+Valentina%22">Tomassini, Valentina</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tortorella%2C+Carla%22">Tortorella, Carla</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Righini%2C+Isabella%22">Righini, Isabella</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Journal+of+Neurology%22">European Journal of Neurology</searchLink>. Apr2021, Vol. 28 Issue 4, p1299-1307. 9p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Magnetic+resonance+imaging%22">Magnetic resonance imaging</searchLink><br /><searchLink fieldCode="DE" term="%22Multiple+sclerosis%22">Multiple sclerosis</searchLink><br /><searchLink fieldCode="DE" term="%22Prognosis%22">Prognosis</searchLink><br /><searchLink fieldCode="DE" term="%22Immunoglobulin+G%22">Immunoglobulin G</searchLink><br /><searchLink fieldCode="DE" term="%22Young+adults%22">Young adults</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Background and purpose: Tumefactive multiple sclerosis (TuMS) (i.e., MS onset presenting with tumefactive demyelinating lesions [TDLs]) is a diagnostic and therapeutic challenge. We performed a multicentre retrospective study to describe the clinical characteristics and the prognostic factors of TuMS. Methods: One hundred two TuMS patients were included in this retrospective study. Demographic, clinical, magnetic resonance imaging (MRI), laboratory data and treatment choices were collected. Results: TuMS was found to affect women more than men (female:male: 2.4), with a young adulthood onset (median age: 29.5 years, range: 11–68 years, interquartile range [IQR]: 38 years). At onset, 52% of TuMS patients presented with the involvement of more than one functional system and 24.5% of them with multiple TDLs. TDLs most frequently presented with an infiltrative MRI pattern (38.7%). Cerebrospinal fluid immunoglobulin G oligoclonal bands were often demonstrated (76.6%). In 25.3% of the cases, more than one acute‐phase treatment was administered, and almost one‐half of the patients (46.6%) were treated with high‐efficacy treatments. After a median follow‐up of 2.3 years (range: 0.1–10.7 years, IQR: 3.4 years), the median Expanded Disability Status Scale (EDSS) score was 1.5 (range: 0–7, IQR: 2). Independent risk factors for reaching an EDSS score ≥3 were a higher age at onset (odds ratio [OR]: 1.08, 95% confidence interval [CI]: 1.03–1.14, p < 0.01), a higher number of TDLs (OR: 1.67, 95% CI: 1.02–2.74, p < 0.05) and the presence of infiltrative TDLs (OR: 3.34, 95% CI: 1.18–9.5, p < 0.001) at baseline. Conclusions: The management of TuMS might be challenging because of its peculiar characteristics. Large prospective studies could help to define the clinical characteristics and the best treatment algorithms for people with TuMS. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of European Journal of Neurology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=149130978 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/ene.14672 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 9 StartPage: 1299 Subjects: – SubjectFull: Magnetic resonance imaging Type: general – SubjectFull: Multiple sclerosis Type: general – SubjectFull: Prognosis Type: general – SubjectFull: Immunoglobulin G Type: general – SubjectFull: Young adults Type: general Titles: – TitleFull: Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Di Gregorio, Maria – PersonEntity: Name: NameFull: Torri Clerici, Valentina Liliana Adriana – PersonEntity: Name: NameFull: Fenu, Giuseppe – PersonEntity: Name: NameFull: Gaetani, Lorenzo – PersonEntity: Name: NameFull: Gallo, Antonio – PersonEntity: Name: NameFull: Cavalla, Paola – PersonEntity: Name: NameFull: Ragonese, Paolo – PersonEntity: Name: NameFull: Annovazzi, Pietro – PersonEntity: Name: NameFull: Gajofatto, Alberto – PersonEntity: Name: NameFull: Prosperini, Luca – PersonEntity: Name: NameFull: Landi, Doriana – PersonEntity: Name: NameFull: Nicoletti, Carolina Gabri – PersonEntity: Name: NameFull: Di Carmine, Caterina – PersonEntity: Name: NameFull: Totaro, Rocco – PersonEntity: Name: NameFull: Nociti, Viviana – PersonEntity: Name: NameFull: De Fino, Chiara – PersonEntity: Name: NameFull: Ferraro, Diana – PersonEntity: Name: NameFull: Tomassini, Valentina – PersonEntity: Name: NameFull: Tortorella, Carla – PersonEntity: Name: NameFull: Righini, Isabella IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: Apr2021 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 13515101 Numbering: – Type: volume Value: 28 – Type: issue Value: 4 Titles: – TitleFull: European Journal of Neurology Type: main |
| ResultId | 1 |